Related Experiment Video
Updated: Oct 22, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Novel effects of acute COVID-19 on cardiac mechanical function: Two case studies
Jyotpal Singh1, Lanishen Bhagaloo2,3, Eric Sy4,5
1Faculty of Kinesiology and Health Studies, University of Regina, Regina, Saskatchewan, Canada.
Insights
COVID-19 can cause varying cardiac damage, impacting systolic and diastolic function. Daily monitoring reveals unique, day-to-day changes in heart mechanics, aiding personalized cardiovascular treatment.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- The COVID-19 pandemic has raised concerns about its impact on cardiovascular health.
- Research indicates COVID-19 can lead to acute cardiac injury, evidenced by elevated biomarkers and echocardiographic findings of mechanical dysfunction.
- Dysfunction affects isovolumic, systolic, and diastolic phases of the cardiac cycle.
Observation:
- This study presents two COVID-19 cases with daily assessments of cardiac mechanical function during the acute phase.
- Participant 1 exhibited sustained cardiac impairments, including altered systolic time, diastolic time, isovolumic time, and heart performance index (HPI), even 23 days post-symptom onset.
- Participant 1 also showed prolonged systole relative to diastole, suggesting elevated pulmonary artery pressure. Participant 2 displayed transient systolic changes and HPI alterations within the first 3 days post-onset, normalizing by day 4.
Findings:
- Cardiac function in COVID-19 patients is altered and can change dynamically day-to-day during the acute infection period.
- COVID-19 induces unique patterns of cardiac damage, necessitating case-by-case, day-to-day study.
- Daily cardiac function monitoring provides detailed insights into the mechanisms of cardiac dysfunction.
Implications:
- Daily assessment of cardiac mechanical function can reveal dynamic changes in COVID-19 patients.
- Understanding these day-to-day variations is crucial for characterizing COVID-19's cardiovascular impact.
- This approach may facilitate personalized cardiovascular treatment strategies for COVID-19 survivors.
Abstract:
The spread of the novel coronavirus 2019 (COVID-19) has caused a global pandemic. The disease has spread rapidly, and research shows that COVID-19 can induce long-lasting cardiac damage. COVID-19 can result in elevated cardiac biomarkers indicative of acute cardiac injury, and research utilizing echocardiography has shown that there is mechanical dysfunction in these patients as well, especially when observing the isovolumic, systolic, and diastolic portions of the cardiac cycle. The purpose of this study was to present two case studies on COVID-19 positive patients who had their cardiac mechanical function assessed every day during the acute period to show that cardiac function in these patients was altered, and the damage occurring can change from day-to-day. Participant 1 showed compromised cardiac function in the systolic time, diastolic time, isovolumic time, and the calculated heart performance index (HPI), and these impairments were sustained even 23 days post-symptom onset. Furthermore, Participant 1 showed prolonged systolic periods that lasted longer than the diastolic periods, indicative of elevated pulmonary artery pressure. Participant 2 showed decreases in systole and consequently, increases in HPI during the 3 days post-symptom onset, and these changes returned to normal after day 4. These results showed that daily observation of cardiac function can provide detailed information about the overall mechanism by which cardiac dysfunction is occurring and that COVID-19 can induce cardiac damage in unique patterns and thus can be studied on a case-by-case basis, day-to-day during infection. This could allow us to move toward more personalized cardiovascular medical treatment.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

